Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics …
EM McCarthy, E Sutton, S Nesbit, J White… - …, 2018 - academic.oup.com
Objectives To describe the baseline characteristics of SLE patients requiring biologic therapy
in the UK and to explore short term efficacy and infection rates associated with rituximab (…
in the UK and to explore short term efficacy and infection rates associated with rituximab (…
[HTML][HTML] Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress
AM Mahmoud, FL Wilkinson, EM McCarthy… - The FASEB …, 2017 - ncbi.nlm.nih.gov
Endothelial microparticles (EMPs) are endothelium-derived submicron vesicles that are
released in response to diverse stimuli and are elevated in cardiovascular disease, which is …
released in response to diverse stimuli and are elevated in cardiovascular disease, which is …
The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients
EM McCarthy, S Smith, RZ Lee, G Cunnane… - …, 2014 - academic.oup.com
Objective. The aim of this study was to explore the role of cytokines in the pathogenesis of
SLE in a genetically homogeneous Caucasian SLE patient population. Methods. Serum levels …
SLE in a genetically homogeneous Caucasian SLE patient population. Methods. Serum levels …
[HTML][HTML] Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations
JA Reynolds, EM McCarthy, S Haque… - Arthritis research & …, 2018 - Springer
Background Patients with SLE display marked clinical and immunlogical heterogeneity. The
purpose of the study was to investigate patterns of serum cytokines in patients with active …
purpose of the study was to investigate patterns of serum cytokines in patients with active …
Elevated B lymphocyte stimulator levels are associated with increased damage in an Irish systemic lupus erythematosus cohort
EM McCarthy, RZ Lee, J Ní Gabhann, S Smith… - …, 2013 - academic.oup.com
Objective. The overall aim of this study is to identify clinical and serological features that are
associated with B lymphocyte stimulator (BLyS) elevation in a homogeneous Caucasian …
associated with B lymphocyte stimulator (BLyS) elevation in a homogeneous Caucasian …
[HTML][HTML] IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation
…, JN Gabhann, K Cunningham, A Widaa, EM McCarthy… - JCI insight, 2018 - ncbi.nlm.nih.gov
Severe lung inflammation and alveolar hemorrhage can be life-threatening in systemic lupus
erythematosus (SLE) patients if not treated early and aggressively. Neutrophil influx is the …
erythematosus (SLE) patients if not treated early and aggressively. Neutrophil influx is the …
Knowledge, attitudes, and clinical practice of rheumatologists in vaccination of the at-risk rheumatology patient population
EM McCarthy, MA Azeez, FM Fitzpatrick… - JCR: Journal of …, 2012 - journals.lww.com
Background Patients with inflammatory arthritis are at increased risk of infection. Much of
the burden of infection in this population is vaccine preventable. A number of international …
the burden of infection in this population is vaccine preventable. A number of international …
Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational survey
P Ngamjanyaporn, EM McCarthy… - Lupus Science & …, 2017 - lupus.bmj.com
Background The definition of remission in systemic lupus erythematosus (SLE) remains
unclear, especially how background treatment should be interpreted. Objective To determine …
unclear, especially how background treatment should be interpreted. Objective To determine …
[HTML][HTML] Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles
…, S Haque, H Chinoy, AL Herrick, EM McCarthy… - Arthritis research & …, 2019 - Springer
Objectives To investigate the relationships between interferon alpha (IFNα) and the clinical
and serological phenotype of patients with systemic autoimmune rheumatic disease (SARDs) …
and serological phenotype of patients with systemic autoimmune rheumatic disease (SARDs) …
QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus
…, JA Reynolds, MY Alexander, EM McCarthy… - Lupus science & …, 2018 - lupus.bmj.com
Objective 10-year cardiovascular disease (CVD) risk scores are calculated using algorithms,
including Framingham (worldwide) and QRISK2 (UK). Recently, an updated QRISK3 model …
including Framingham (worldwide) and QRISK2 (UK). Recently, an updated QRISK3 model …